TABLE 2.
Immune response to vaccination with live oral cholera vaccine CVD 103-HgR as measured by serum Inaba vibriocidal reciprocal GMT and by the mean optical density for anti-cholera toxin assays
| Group | Inaba vibriocidal
reciprocal titer (range)
|
Anti-cholera toxin IgG (range)
|
||||
|---|---|---|---|---|---|---|
| Seroconversion rate (%) | Pre | Post | Seroconversion rate (%) | Pre | Post | |
| All vaccinees (n = 43) | 91 | 27 (10–640) | 3,056 (20–20,480) | 51 | 0.12 (0.01–0.83) | 0.67 (0.03–2.43) |
| All placebo recipients (n = 42) | 2 | 23 (10–640) | 26 (10–640) | 5 | 0.14 (0.00–0.38) | 0.15 (0.02–0.41) |